Volpara Health Technologies Limited
VPAHF · OTC
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Revenue | $32,772 | $24,271 | $18,128 | $12,321 |
| % Growth | 35% | 33.9% | 47.1% | – |
| Cost of Goods Sold | $2,474 | $2,128 | $1,553 | $1,728 |
| Gross Profit | $30,298 | $22,142 | $16,575 | $10,594 |
| % Margin | 92.5% | 91.2% | 91.4% | 86% |
| R&D Expenses | $16,550 | $15,650 | $13,009 | $10,632 |
| G&A Expenses | $12,450 | $11,394 | $11,514 | $11,593 |
| SG&A Expenses | $26,738 | $24,519 | $22,790 | $24,509 |
| Sales & Mktg Exp. | $14,288 | $13,125 | $11,276 | $12,916 |
| Other Operating Expenses | $2,518 | $2,985 | $1,392 | $2,154 |
| Operating Expenses | $48,420 | $44,499 | $38,635 | $37,325 |
| Operating Income | -$10,298 | -$14,881 | -$17,262 | -$21,642 |
| % Margin | -31.4% | -61.3% | -95.2% | -175.6% |
| Other Income/Exp. Net | $1,171 | $3,225 | $2,159 | $2,244 |
| Pre-Tax Income | -$10,652 | -$15,014 | -$17,396 | -$21,714 |
| Tax Expense | -$1,478 | $267 | -$1,341 | -$1,888 |
| Net Income | -$9,174 | -$15,281 | -$16,054 | -$19,825 |
| % Margin | -28% | -63% | -88.6% | -160.9% |
| EPS | -0.036 | -0.061 | -0.065 | -0.094 |
| % Growth | 40.1% | 6.3% | 31.2% | – |
| EPS Diluted | -0.036 | -0.061 | -0.065 | -0.094 |
| Weighted Avg Shares Out | 252,202 | 251,375 | 247,257 | 210,136 |
| Weighted Avg Shares Out Dil | 252,202 | 251,375 | 247,257 | 210,136 |
| Supplemental Information | – | – | – | – |
| Interest Income | $174 | $161 | $571 | $752 |
| Interest Expense | $355 | $134 | $134 | $72 |
| Depreciation & Amortization | $5,132 | $4,330 | $2,836 | $2,184 |
| EBITDA | -$6,827 | -$13,848 | -$16,670 | -$19,493 |
| % Margin | -20.8% | -57.1% | -92% | -158.2% |